<?xml version="1.0" encoding="UTF-8"?>
<p id="Par9">Hydroxychloroquine is FDA-approved to prevent and treat malaria, as well as to treat the autoimmune diseases rheumatoid arthritis and lupus [
 <xref ref-type="bibr" rid="CR44">44</xref>–
 <xref ref-type="bibr" rid="CR48">48</xref>]. Some preliminary reports have suggested that hydroxychloroquine, alone or in combination with the FDA-approved antibiotic azithromycin, may benefit people with COVID-19. Numerous clinical trials are planned or underway, including a recently launched study supported by NIH’s National Heart, Lung and Blood Institute, evaluating the safety and effectiveness of hydroxychloroquine for treatment of adults hospitalized with COVID-19.
</p>
